Principle Investigator: Tao Guo

Members: Lintao Xian, Fan Liang, Hao Luo, Li Zhao, Jianming Liu, Ming Feng, Jian Meng, Fujun Peng, Shunshun Zhu.

Background: Our team was established in 2022, evolving from the Youth Innovation Project of Higher Education Institutions in Shandong Province, and is currently supported by Shandong Second Medical University and the Shandong Provincial Department of Education. Our primary research focus is on the molecular dysregulation mechanisms of hepatocellular carcinoma, encompassing the genetic and epigenetic regulation of genes, as well as functional studies. The core members of our team are graduates of prestigious Chinese universities, including Wuhan University, Fudan University, and Qingdao University. Each member's research expertise spans a wide range of disciplines, including clinical oncology, molecular biology, diagnostic pathology, artificial intelligence and neural networks, and bioinformatics. Our team is dedicated to interdisciplinary integration, leveraging our respective strengths and complementary knowledge to achieve groundbreaking advancements in the understanding of tumorigenesis and AI-assisted clinical translation.